Episode Details

Back to Episodes
HRT and WHI (Part 2): NAMS 2017 Updated Statement

HRT and WHI (Part 2): NAMS 2017 Updated Statement

Published 7 years, 2 months ago
Description
This is Part 2 of our critical reappraisal of the WHI study. In this episode we will cover the NAMS 2017 guidelines on HRT use. Does hormone therapy increase breast cancer in BRCA carriers? What is the data on ovarian cancer? Dementia? Listen to find out! We will also briefly touch on transdermal hormone replacement therapy, at the end of the podcast.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us